Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRICE FORECAST
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
Yong'an Pharma reports slumps in H1 results, while Jinyao Pharma's H1 net profit grows substantially
Read online
Yong'an Pharma reports slumps in H1 results, while Jinyao Pharma's H1 net profit grows substantially
Summary: In H1 2023, Yong'an Pharma's revenue from taurine fell by 42.95% YoY because its taurine export business was impeded; gross profit margin of Jinyao Pharma's amino acid APIs grew by 7.35 percentage points YoY, marking the highest growth speed...
Amino Acids China E-News 202309
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...